Next Generation News and Research

RSS

Researchers develop antibiotic "smart bomb" that can identify specific strains of bacteria

Researchers from North Carolina State University have developed a de facto antibiotic "smart bomb" that can identify specific strains of bacteria and sever their DNA, eliminating the infection. The technique offers a potential approach to treat infections by multi-drug resistant bacteria.

31 Jan 2014

Zimmer Holdings fourth quarter net sales increase 5.1% to $1.24 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2013. The Company reported fourth quarter net sales of $1.24 billion, an increase of 5.1% reported and 6.6% constant currency over the fourth quarter of 2012.

30 Jan 2014

Nanomix announces closure of private financing for $12M

Nanomix Inc., (Nanomix), a leading nanotechnology company focused on development of next generation Point of Care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings, today announced that is has closed private financing for approximately $12 million.

30 Jan 2014

Thermo Fisher Scientific fourth quarter revenue increases 6% to $3.47 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2013.

30 Jan 2014

University of Liverpool receives funding to continue reducing impact of adverse reactions to medicinal drugs

The Medical Research Council (MRC) Centre for Drug Safety Science at the University of Liverpool has received three million pounds of new funding from MRC to allow it to continue reducing the impact of adverse reactions to medicinal drugs.

30 Jan 2014

CU receives cooperative agreement to develop technological system to determine effects chemical agents

The University of Colorado Boulder has been awarded a cooperative agreement worth up to $14.6 million from the Defense Advanced Research Projects Agency (DARPA) to develop a new technological system to rapidly determine how drugs and biological or chemical agents exert their effects on human cells.

29 Jan 2014

Saudi Aramco, Johns Hopkins Medicine partner to strengthen health care services in Saudi Arabia

Saudi Aramco, a fully integrated global energy and chemicals enterprise, and Johns Hopkins Medicine, a leading U.S. academic health system with extensive experience in elevating care delivery worldwide, today inaugurated a first-of-its-kind health care joint venture in Dhahran, Saudi Arabia.

29 Jan 2014

Biologists identify protein targets for next-generation of anti-HIV drugs

People infected with the Human Immunodeficiency Virus (HIV) can stave off the symptoms of AIDS thanks to drug cocktails that mainly target three enzymes produced by the virus, but resistant strains pop up periodically that threaten to thwart these drug combos.

29 Jan 2014

Claret receives CE Mark for Sentinel CPS for embolic protection during aortic valve replacement

Claret Medical, Inc., a developer of innovative solutions for cerebral protection during structural heart interventions, vascular interventions, and cardiac surgery procedures, announced that it has received CE Mark for the Sentinel Cerebral Protection System for embolic protection during Transcatheter Aortic Valve Replacement.

28 Jan 2014

New halal testing method for detecting pig and horse contamination of meat

The mislabeling of meat products sold for human consumption has serious implications from a safety and ethical perspective. With recent news stories of pork and horsemeat contamination in different parts of the world, a renewed need for specialized testing of the food supply has rapidly arisen.

28 Jan 2014

GenePeeks receives patent for developing innovative algorithms to create hypothetical "digital babies"

GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.

28 Jan 2014

Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

The Myelin Repair Foundation today announced it has entered a Cooperative Research and Development Agreement with the National Institutes of Health to assess MRF-008, as a potential therapeutic for multiple sclerosis. This CRADA will facilitate collaboration between the MRF and National Institute of Neurological Disorders and Stroke at the NIH Clinical Center to study MRF-008, a drug identified by the MRF as a potential neuroprotective therapeutic to enhance repair in multiple sclerosis patients.

27 Jan 2014

DKFZ, AstraZeneca EORTC join Worldwide Innovative Network Consortium

The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine is proud to announce that AstraZeneca, DKFZ and EORTC have joined the Consortium.

27 Jan 2014

UM professors receive grant to help athletes, military members suffering from traumatic brain injury

Athletes, members of the military and others suffering from traumatic brain injury may benefit from research conducted by two University of Montana faculty members through a new $300,000 grant awarded by General Electric Co. and the National Football League.

25 Jan 2014

Collaboration between NFL and GE seeks to improve safety of athletes, soldiers who sustain mild TBI

When the Broncos and the Seahawks meet on the gridiron for Superbowl XLVIII, player and team statistics - passer ratings, rushing yards, sacks and fumbles - will be tossed around like, well, a football.

24 Jan 2014

Researchers use advanced neuroimaging techniques to study how concussions affect blood flow in brain

Researchers at the Indiana University School of Medicine will use advanced neuroimaging techniques to study area high school athletes to learn how concussions affect blood flow in the brain.

24 Jan 2014

Next-generation high content screening system launched by PerkinElmer

PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has announced the launch of the Opera Phenix™, a next-generation, confocal, high-content screening system that will enable scientists to perform the most challenging applications with greater speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatments.

23 Jan 2014

Exposing adolescent to marijuana can lead to behavioral alterations in next generation

Exposing adolescent rats to THC (tetrahydrocannabinol) -the primary psychoactive ingredient in marijuana—can lead to molecular and behavioral alterations in the next generation of offspring, even though progeny were not directly exposed to the drug, researchers at the Icahn School of Medicine at Mount Sinai have found.

23 Jan 2014

NCCC physicians use new gene sequencing equipment for testing abnormal DNA in cancerous tumor cells

Clinical laboratory experts and physicians at Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) achieved 100 percent accuracy in testing for abnormal DNA in cancerous tumor cells with its new gene sequencing equipment and panels.

23 Jan 2014

Scientists develop new genetic platform that yields novel antibiotic from ocean bacteria

Scientists at the University of California, San Diego have developed a new genetic platform that allows efficient production of naturally occurring molecules, and have used it to produce a novel antibiotic compound.

23 Jan 2014

Next Generation News and Research

Researchers develop antibiotic "smart bomb" that can identify specific strains of bacteria

Zimmer Holdings fourth quarter net sales increase 5.1% to $1.24 billion

Nanomix announces closure of private financing for $12M

Thermo Fisher Scientific fourth quarter revenue increases 6% to $3.47 billion

University of Liverpool receives funding to continue reducing impact of adverse reactions to medicinal drugs

CU receives cooperative agreement to develop technological system to determine effects chemical agents

Saudi Aramco, Johns Hopkins Medicine partner to strengthen health care services in Saudi Arabia

Biologists identify protein targets for next-generation of anti-HIV drugs

Claret receives CE Mark for Sentinel CPS for embolic protection during aortic valve replacement

New halal testing method for detecting pig and horse contamination of meat

GenePeeks receives patent for developing innovative algorithms to create hypothetical "digital babies"

Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

DKFZ, AstraZeneca EORTC join Worldwide Innovative Network Consortium

UM professors receive grant to help athletes, military members suffering from traumatic brain injury

Collaboration between NFL and GE seeks to improve safety of athletes, soldiers who sustain mild TBI

Researchers use advanced neuroimaging techniques to study how concussions affect blood flow in brain

Next-generation high content screening system launched by PerkinElmer

Exposing adolescent to marijuana can lead to behavioral alterations in next generation

NCCC physicians use new gene sequencing equipment for testing abnormal DNA in cancerous tumor cells

Scientists develop new genetic platform that yields novel antibiotic from ocean bacteria

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News